Skip to main content
Premium Trial:

Request an Annual Quote

Ronald Matricaria, William Mercer, Werner Schafer, Erich Mayer, Augustine Yee, Robert Brown, Daniel Von Hoff

Premium

Ronald Matricaria has been appointed to the board of directors of Invitrogen, the company announced last week. He replaces William Mercer, who is retiring. Matricaria was formerly the chairman and CEO of St. Jude Medical, where he increased revenues from $225 million to more than $1 billion. Prior to that, he worked for Eli Lilly, serving as CEO of Lilly subsidiary Cardiac Pacemakers and as executive vice president of the pharmaceutical division of Eli Lilly, in addition to other roles.


Werner Schafer joined the supervisory board of BioVision July 1. Schafer replaced Erich Mayer. Schafer is the chairman of the Brahms biotechnology company in Berlin, and has many years of experience in the pharmaceutical and diagnostic industry. BioVision specializes in the identification of disease-relevant peptides and proteins using its Peptidomics technologies.


Augustine Yee was appointed as vice president of business development for Archemix. Yee comes to Archemix from Prometheus Laboratories, where he was vice president and head of business and corporate development. He holds a BS in molecular biology from the University of California at San Diego and a JD from Pepperdine University School of Law.


Robert Brown has been named vice president of corporate development for Serologicals. Most recently, Brown was senior vice president of corporate development at Andrx. Brown holds a BS in chemistry from Neumann College.


Daniel Von Hoff has been appointed to the scientific advisory board of Halozyme Therapeutics. Von Hoff is currently a professor of medicine, pathology and molecular and cellular biology at Arizona Health Sciences Center. He is also head of the Translational Genomics Research.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.